SRQ BIO, INC.
SARASOTA, FLORIDA

SRQ Bio, Inc. is a wholly-owned subsidiary of The Roskamp Institute, Inc., headquartered in Sarasota, Florida. Incorporated on March 2, 2016, SRQ Bio specializes in advancing drug and nutraceutical therapies efficiently and cost-effectively. They leverage over two decades of combined experience from their executive leadership team, including expertise in science, research, and business disciplines. The company's core operations are supported by a science team that has been actively engaged in the lab for more than ten years. SRQ Bio's Vice President of Business Development, Dr. Benoit Mouzon, is dedicated to strategic expansion utilizing his extensive background in sales and project management within biotech and real estate sectors. Holding qualifications from esteemed institutions like SKEMA Business School, McGill University, and the Open University, Dr. Mouzon is at the helm of driving growth. Mr. Park Dodd serves as a key member with substantial experience spanning financial reporting, budgeting, forecasting, and strategic IT management. His previous roles have included positions at KPMG, Philip Morris USA, Capital One Financial, Inc., Rock Creek Pharmaceuticals, Inc., and Tatum LLC. SRQ Bio is recognized legally under the Florida Companies Registry, Filed Number P16000019713, and maintains an active annual report status marked as of March 18, 2024. The company's contact information includes a mailing address at 2040 Whitfield Avenue, Sarasota, FL 34243, with phone reach at (941) 251-8080. The registered officers include Fiona Crawford as Director and Park Dodd in another executive capacity.